Literature DB >> 10801448

Phosphatidylinositol 3-kinase regulates Raf1 through Pak phosphorylation of serine 338.

A Chaudhary1, W G King, M D Mattaliano, J A Frost, B Diaz, D K Morrison, M H Cobb, M S Marshall, J S Brugge.   

Abstract

We have previously shown that inhibition of phosphatidylinositol (PI) 3-kinase severely attenuates the activation of extracellular signal-regulated kinase (Erk) following engagement of integrin/fibronectin receptors and that Raf is the critical target of PI 3-kinase regulation [1]. To investigate how PI 3-kinase regulates Raf, we examined sites on Raf1 required for regulation by PI 3-kinase and explored the mechanisms involved in this regulation. Serine 338 (Ser338), which was critical for fibronectin stimulation of Raf1, was phosphorylated in a PI 3-kinase-dependent manner following engagement of fibronectin receptors. In addition, fibronectin activation of a Raf1 mutant containing a phospho-mimic mutation (S338D) was independent of PI 3-kinase. Furthermore, integrin-induced activation of the serine/threonine kinase Pak-1, which has been shown to phosphorylate Raf1 Ser338, was also dependent on PI 3-kinase activity and expression of a kinase-inactive Pak-1 mutant blocked phosphorylation of Raf1 Ser338. These results indicate that PI 3-kinase regulates phosphorylation of Raf1 Ser338 through the serine/threonine kinase Pak. Thus, phosphorylation of Raf1 Ser338 through PI 3-kinase and Pak provides a co-stimulatory signal which together with Ras leads to strong activation of Raf1 kinase activity by integrins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10801448     DOI: 10.1016/s0960-9822(00)00475-9

Source DB:  PubMed          Journal:  Curr Biol        ISSN: 0960-9822            Impact factor:   10.834


  67 in total

1.  A PAK1-PIX-PKL complex is activated by the T-cell receptor independent of Nck, Slp-76 and LAT.

Authors:  G M Ku; D Yablonski; E Manser; L Lim; A Weiss
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

2.  S338 phosphorylation of Raf-1 is independent of phosphatidylinositol 3-kinase and Pak3.

Authors:  A Chiloeches; C S Mason; R Marais
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

3.  A computational model on the modulation of mitogen-activated protein kinase (MAPK) and Akt pathways in heregulin-induced ErbB signalling.

Authors:  Mariko Hatakeyama; Shuhei Kimura; Takashi Naka; Takuji Kawasaki; Noriko Yumoto; Mio Ichikawa; Jae-Hoon Kim; Kazuki Saito; Mihoro Saeki; Mikako Shirouzu; Shigeyuki Yokoyama; Akihiko Konagaya
Journal:  Biochem J       Date:  2003-07-15       Impact factor: 3.857

Review 4.  Mechanistic principles of RAF kinase signaling.

Authors:  Christian M Udell; Thanashan Rajakulendran; Frank Sicheri; Marc Therrien
Journal:  Cell Mol Life Sci       Date:  2010-09-06       Impact factor: 9.261

5.  Akt down-regulates ERK1/2 nuclear localization and angiotensin II-induced cell proliferation through PEA-15.

Authors:  Marianne Gervais; Céline Dugourd; Laurent Muller; Corinne Ardidie; Brigitte Canton; Laetitia Loviconi; Pierre Corvol; Hervé Chneiweiss; Catherine Monnot
Journal:  Mol Biol Cell       Date:  2006-07-05       Impact factor: 4.138

6.  Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation.

Authors:  Fumitaka Koga; Wanping Xu; Tatiana S Karpova; James G McNally; Roland Baron; Len Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

7.  Polyoma and SV40 proteins differentially regulate PP2A to activate distinct cellular signaling pathways involved in growth control.

Authors:  Pablo Rodriguez-Viciana; Crista Collins; Mike Fried
Journal:  Proc Natl Acad Sci U S A       Date:  2006-12-08       Impact factor: 11.205

Review 8.  Aging of signal transduction pathways, and pathology.

Authors:  Morgan E Carlson; Haroldo S Silva; Irina M Conboy
Journal:  Exp Cell Res       Date:  2008-04-07       Impact factor: 3.905

Review 9.  Extracellular-Regulated Kinases: Signaling From Ras to ERK Substrates to Control Biological Outcomes.

Authors:  Scott T Eblen
Journal:  Adv Cancer Res       Date:  2018-03-02       Impact factor: 6.242

10.  Multipathway model enables prediction of kinase inhibitor cross-talk effects on migration of Her2-overexpressing mammary epithelial cells.

Authors:  Neil Kumar; Raffi Afeyan; Hyung-Do Kim; Douglas A Lauffenburger
Journal:  Mol Pharmacol       Date:  2008-03-18       Impact factor: 4.436

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.